Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review

OBJECTIVE: The combination of a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist (LABA) in a single inhaler is a viable treatment option for patients with chronic obstructive pulmonary disease (COPD). Here, we systematically review the current knowledge on double bronchodilati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Campos, Jose Luis, Calero-Acuña, Carmen, Márquez-Martín, Eduardo, Quintana Gallego, Esther, Carrasco-Hernández, Laura, Abad Arranz, Maria, Ortega Ruiz, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491571/
https://www.ncbi.nlm.nih.gov/pubmed/28694697
http://dx.doi.org/10.2147/COPD.S132962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491571/
https://www.ncbi.nlm.nih.gov/pubmed/28694697
http://dx.doi.org/10.2147/COPD.S132962

Ejemplares similares